Nodular goiter and goiter nodules: Where iodine deficiency falls short of explaining the facts

Experimental and Clinical Endocrinology and Diabetes

Volumn 109, Issue 5, 2001, Pages 250-260

  Derwahl, M ^a   Studer, H ^a  

^a St Hedwig Hospital   (Germany)

Author keywords

Heterogeneity; Iodine deficiency; Molecular aspects; Neoplasia; Nodular goiter; Pathogenesis; Sporadic goiter

Indexed keywords

IODINE; THYROTROPIN;

GENETIC PREDISPOSITION; HUMAN; IODINE DEFICIENCY; NODULAR GOITER; PRIORITY JOURNAL; REVIEW; THYROID FUNCTION; THYROID SCINTISCANNING; THYROTOXICOSIS; THYROTROPIN BLOOD LEVEL; THYROTROPIN RELEASE;

FEMALE; GOITER, NODULAR; GONADAL STEROID HORMONES; HUMANS; HYPERPLASIA; IODINE; MALE; THYROID GLAND; THYROID NEOPLASMS; THYROTROPIN;

EID: 0034903463     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2001-16344     Document Type: Review

References (77)

1. Familial tendency and dietary association of goitre in Gamo-Gofa, Ethiopia
2. Low intrathyroidal iodine concentration in non endemic human goiters: A consequence rather than a cause of autonomous goiter growth
3. The degree of inhibition of follicular cell proliferation by iodide is a highly individual characteristic of each cell and differs profoundly in vitro and in vivo
4. Morphological and functional polymorphism within clonal thyroid nodules
5. Notch signaling: Cell fate control and signal integration in development
6. Acquired and naturally occurring resistance of thyroid follicular cells to the growth inhibitory action of transforming growth factor β1(TGF β1)
7. Growth factors and goitrogenesis
8. Familial nontoxic multinodular thyroid goiter locus maps to chromosome 14q but does not account for familial nonmedullary thyroid cancer
9. Molecular themes in oncogenesis
10. Major role of genes in the etiology of simple goiter in females: A population based twin study
11. Expression of apoptosis-related proteins in thyroid tumors and thyroid carcinoma cell lines
12. Thyrotropin via cyclic AMP induces insulin receptor expression and insulin co-stimulation of growth and amplifies insulin and insulin-like growth factor signaling pathways in dog thyroid epithelial cells
13. Irreversibility of cellular aging and neoplastic transformation: A clonal analysis
14. Estrogen and thyroid-stimulating hormone (TSH) receptors in neoplastic and nonneoplastic human thyroid tissue
15. Iodine deficiency
16. Neonatal thyroid screening as a tool for the control of iodine deficiency
17. Characterization of autonomous thyroid adenoma: Metabolism, gene expression, and pathology
18. Editorial: TSH receptor and Gs-alpha gene mutations in the pathogenesis of toxic thyroid adenomas: A note of caution
19. Clinical review 101: Thyrotropin may not be the dominant growth factor in benign and malignant thyroid tumors
20. Constitutive activation of the Gsα-protein-adenylate cyclase pathway may not be sufficient to generate toxic thyroid adenomas
21. Intercellular propagation of individually programmed growth bursts in FRTL-5 cells. Implications for interpreting growth factor actions
22. Pathogenesis and treatment of multinodular goiter
23. Epidermal growth factor and thyrotropin response in human thyroid tissues
24. Physiological and pathological regulation of thyroid cell proliferation and differentiation by thyrotropin and other factors
25. Functional human thyroid cells and their insulin-like growth factor-binding proteins: Regulation by thyrotropin, cyclic 3′,5′ adenosine monophosphate and growth factors
26. Molecular pathogenesis of tumors of thyroid follicular cells
27. Reciprocal changes of serum thyroglobulin and TSH in residents of a moderate endemic goitre area
28. Germline polymorphism of codon 727 of human thyroid-stimulating hormone receptor is associated with toxic multinodular goiter
29. Role of basis fibroblast growth factor in the pathogenesis of nodular goiter
30. The site of leakage of intrafollicular thyroglobulin into the blood stream in simple human goiter
31. Preclinical hyperthyroidism in multinodular goiter
32. Human nodular goiters grow by episodic replication of disseminated cell cohorts expressing several growth factors at the same time
33. Expression of functional stimulatory guanine nucleotide binding protein in nonfunctioning thyroid adenomas is not correlated to adenylate cyclase activity and growth of these tumors
34. Thyroid nodules in recurrent multinodular goiters are predominantly polyclonal
35. Endogenous hormones as a major factor in human cancer
36. Identification of constitutively activating somatic thyrotropin receptor mutations in a subset of toxic multinodular goiters
37. Immunohistochemical study of estrogen receptors and the responsiveness to estrogen in papillary thyroid carcinoma
38. - symporter in human thyroid tissues and salivary gland tissues
39. 3 in multinodular goiters and differentiated thyroid carcinomas: A comparative study
40. Polyclonal and clonal nodules may coexist within multinodular goiters
41. Possible role of genetic factors in thyroid growth rate and in the assessment of upper limit of normal thyroid volume in iodine-replete adolescents
42. Synergistic and antagonistic effects of sex hormones in the regulation of thyroid tumor growth
43. Estrogen promotes growth of human thyroid tumor cells by different molecular mechanisms
44. Incidence of thyroid cancer in women in relation to previous exposure to radiation therapy and history of thyroid disease
45. Immunoreactive insulin-like growth factor I (IGF-1) and IGF-binding protein content in human thyroid tissue
46. TGF-beta 1 immunohistochemistry in goiter: Comparison of patients with recurrence or no recurrence
47. H-ras protooncogene mutations in human thyroid neoplasms
48. - symporter
49. Cancer incidence and mortality in women receiving estrogen and estrogen-progestin replacement therapy: Long-term follow-up of a Swedish cohort
50. Comparison of FRTL-5 cell growth in vitro with that of xenotransplanted cells and the thyroid of the recipient mouse
51. Pathogenesis of heterogeneity in human nodular goiter
52. The pathogenesis of hot and cold follicles in multinodular goiters
53. Thyroid cancer among young women related to prior thyroid disease and pregnancy history
54. Topographical heterogeneity of basal and thyrotropin-stimulated adenosine 3′,5′-monophosphate in human nodular goiter
55. Cellular aging, destabilization, and cancer
56. A mechanism generating heterogeneity in thyroid epithelial cells: Suppression of the thyrotropin/cAMP-dependent pathway after cell division induced by cAMP independent factors
57. A population-based case-control study of thyroid cancer
58. Inhibitory effect of dihydrotestosterone on human thyroid cell growth
59. Pendrin, the protein encoded by the Pendred syndrome gene (PDS), is an apical porter of iodide in the thyroid and is regulated by thyroglobulin in FRTL-5 cells
60. Cellular aging, destabilization and cancer
61. Activating mutations of the TSH receptor in differentiated thyroid carcinomas
62. Cold follicles in a multinodular human goiter arise partly from a failing iodide pump and partly from deficient iodine organification
63. Apoptosis: The biochemistry and molecular biology of programmed cell death
64. Getting to the guts of enteroendocrine differentiation
65. Mechanisms of nonneoplastic endocrine hyperplasia - A changing concept: A review focused on the thyroid gland
66. Histomorphological and immunohistochemical evidence that human nodular goiters grow by episodic replication of multiple clusters of thyroid follicular cells
67. Natural heterogeneity of thyroid cells: The basis for understanding thyroid function and nodular goiter growth
68. Hypertrophy and hyperplasia during growth and involution in rats - Separate bioeffects of TSH and iodine
69. Gsp mutations in human thyroid tumours
70. Activating thyrotropin receptor mutations in histologically heterogeneous hyperfunctioning nodules of multinodular goiter
71. Activating thyrotropin receptor mutations are present in nonadenomatous hyperfunctioning nodules of toxic or autonomous multinodular goiters
72. Insulin-like growth factor-I receptors in nonfunctioning thyroid nodules
73. EGF-receptors in human normal and pathological thyroid tissue
74. Loss of independence on IGF-I or proliferation of human thyroid adenoma cells
75. Evidence for autocrine production of IGF-1 in human thyroid adenomas
76. Changes in DNA and weight of thyroid glands during hyperplasia and involution
77. Expression of the estrogen receptor in human thyroid neoplasms